MX2017000438A - Solucion cardioplejica de propositos generales (variantes). - Google Patents
Solucion cardioplejica de propositos generales (variantes).Info
- Publication number
- MX2017000438A MX2017000438A MX2017000438A MX2017000438A MX2017000438A MX 2017000438 A MX2017000438 A MX 2017000438A MX 2017000438 A MX2017000438 A MX 2017000438A MX 2017000438 A MX2017000438 A MX 2017000438A MX 2017000438 A MX2017000438 A MX 2017000438A
- Authority
- MX
- Mexico
- Prior art keywords
- solution
- asystole
- maintaining
- heart
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a la medicina, más específicamente a la cirugía cardíaca, y puede utilizarse para proteger al corazón de la isquemia cuando se administra cardioplejia en normotermia o hipotermia; la solución cardiopléjica de uso general contiene iones de potasio farmacéuticamente aceptables; iones de magnesio; una base y un ácido que proporcionan un regulador de pH en una escala de 7.1 a 8.9; un diurético que proporciona osmolalidad en una escala en una escala de 275 a 460 mOsmol/kg; dicha solución se utiliza para protección cardíaca en el bypass cardiopulmonar así como para lograr asistolia y mantener la asistolia alcanzada; el procedimiento para administrar la solución cardiopléjica de uso general implica mantener la asistolia lograda al disminuir el caudal de los componentes de inicio de dicha solución relacionados con el caudal de la autosangre así disminuyendo la solución a la proporción de autosangre.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014128455/15A RU2574957C1 (ru) | 2014-07-11 | Кардиоплегический раствор (варианты) | |
PCT/RU2015/000353 WO2016007041A1 (ru) | 2014-07-11 | 2015-06-05 | Универсальный кардиоплегический раствор (варианты) |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017000438A true MX2017000438A (es) | 2017-08-16 |
Family
ID=55064554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017000438A MX2017000438A (es) | 2014-07-11 | 2015-06-05 | Solucion cardioplejica de propositos generales (variantes). |
Country Status (10)
Country | Link |
---|---|
US (2) | US10646511B2 (es) |
EP (1) | EP3167874B1 (es) |
JP (1) | JP6629850B2 (es) |
CN (2) | CN106659677A (es) |
BR (1) | BR112017000052B1 (es) |
EA (1) | EA035702B1 (es) |
ES (1) | ES2713434T3 (es) |
MX (1) | MX2017000438A (es) |
TR (1) | TR201901995T4 (es) |
WO (1) | WO2016007041A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017000438A (es) | 2014-07-11 | 2017-08-16 | Ltd Liability Company Cardiosystempharma (Llc Csp ) | Solucion cardioplejica de propositos generales (variantes). |
IT201600120839A1 (it) * | 2016-12-01 | 2018-06-01 | Valentina Valenti | Soluzione cardioplegica con attivatori dell'autofagia per l'arresto diastolico del cuore in corso di interventi cardiochirurgici |
WO2020122928A1 (en) * | 2018-12-14 | 2020-06-18 | National Taiwan University | A stable cardioplegic solution for cardiac surgery |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BG52177B2 (en) * | 1986-02-11 | 1998-06-30 | Стефан Н. Найденов | Cardioplegic solution |
CA2066374C (en) * | 1991-04-19 | 2002-01-29 | Paul E. Segall | Solution for perfusing primates |
US5306711A (en) | 1992-06-24 | 1994-04-26 | Georgetown University | Organ preservative solution |
US5405742A (en) * | 1993-07-16 | 1995-04-11 | Cyromedical Sciences, Inc. | Solutions for tissue preservation and bloodless surgery and methods using same |
US5554497A (en) * | 1994-12-12 | 1996-09-10 | Charlotte-Mecklenburg Hospital Authority | Cardioplegic solution for arresting an organ |
US5656420A (en) * | 1995-02-24 | 1997-08-12 | University Of Kentucky Research Foundation | Method for employing the delta opioid dadle to extend tissue survival time during ischemia |
RU2145843C1 (ru) * | 1997-06-16 | 2000-02-27 | Вольгушев Валентин Евгеньевич | Нормотермический кардиоплегический раствор |
US6492103B1 (en) * | 2000-01-31 | 2002-12-10 | Organ Recovery Systems, Inc. | System for organ and tissue preservation and hypothermic blood substitution |
SE0002832D0 (sv) * | 2000-08-07 | 2000-08-07 | Jostra Ab | Cardioplegic solution |
RU2195878C2 (ru) | 2000-09-21 | 2003-01-10 | Областная клиническая больница № 1 Свердловской области | Способ защиты больного при проведении операций аортокоронарного шунтирования |
RU2226093C1 (ru) * | 2002-11-05 | 2004-03-27 | Российский кардиологический научно-производственный комплекс Министерства здравоохранения РФ | Кардиоплегический раствор "инфузол" |
WO2007105179A1 (en) * | 2006-03-15 | 2007-09-20 | Universitat Bern | Cardioplegic solution |
EP2252292A4 (en) * | 2008-02-15 | 2011-03-16 | Harvard College | CARDIOPLEGIA SOLUTION FOR HEART OPERATIONS |
RU2413502C1 (ru) * | 2009-07-24 | 2011-03-10 | Учреждение Российской академии медицинских наук Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева РАМН | Кардиоплегический раствор "асн-бокерия-болдырева" |
MX2017000438A (es) | 2014-07-11 | 2017-08-16 | Ltd Liability Company Cardiosystempharma (Llc Csp ) | Solucion cardioplejica de propositos generales (variantes). |
-
2015
- 2015-06-05 MX MX2017000438A patent/MX2017000438A/es unknown
- 2015-06-05 BR BR112017000052-0A patent/BR112017000052B1/pt active IP Right Grant
- 2015-06-05 EA EA201700032A patent/EA035702B1/ru unknown
- 2015-06-05 CN CN201580037619.2A patent/CN106659677A/zh active Pending
- 2015-06-05 WO PCT/RU2015/000353 patent/WO2016007041A1/ru active Application Filing
- 2015-06-05 JP JP2017522314A patent/JP6629850B2/ja active Active
- 2015-06-05 ES ES15819585T patent/ES2713434T3/es active Active
- 2015-06-05 CN CN202211187936.0A patent/CN115813947A/zh active Pending
- 2015-06-05 TR TR2019/01995T patent/TR201901995T4/tr unknown
- 2015-06-05 US US15/325,501 patent/US10646511B2/en active Active
- 2015-06-05 EP EP15819585.9A patent/EP3167874B1/en active Active
-
2020
- 2020-04-08 US US16/843,376 patent/US10987378B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BR112017000052B1 (pt) | 2022-09-13 |
BR112017000052A2 (pt) | 2017-11-07 |
US10987378B2 (en) | 2021-04-27 |
US20170143760A1 (en) | 2017-05-25 |
TR201901995T4 (tr) | 2019-03-21 |
JP6629850B2 (ja) | 2020-01-15 |
JP2017520629A (ja) | 2017-07-27 |
EP3167874B1 (en) | 2018-12-26 |
EA201700032A1 (ru) | 2017-05-31 |
EA035702B1 (ru) | 2020-07-28 |
ES2713434T3 (es) | 2019-05-21 |
US10646511B2 (en) | 2020-05-12 |
RU2014128455A (ru) | 2016-02-10 |
CN106659677A (zh) | 2017-05-10 |
EP3167874A1 (en) | 2017-05-17 |
CN115813947A (zh) | 2023-03-21 |
US20200230171A1 (en) | 2020-07-23 |
EP3167874A4 (en) | 2017-12-27 |
WO2016007041A1 (ru) | 2016-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2017000452A1 (en) | Compositions of obeticholic acid and methods of use | |
PE20181093A1 (es) | Compuestos heterociclicos y usos de los mismos | |
MX2019006207A (es) | Forma polimorfica de sepiapterina. | |
MX2018010788A (es) | Composicion oftalmologica. | |
EA201591743A1 (ru) | СТИМУЛЯТОРЫ sGC | |
CA2946953C (en) | An aqueous pharmaceutical composition of adalimumab | |
BR112018069251A2 (pt) | métodos de intervenção precoce para prevenir ou melhorar a toxicidade | |
PE20161368A1 (es) | Inhibidores de diacilglicerol aciltranferasa 2 | |
AR088381A1 (es) | Formulaciones de etanercept estabilizadas con meglumina | |
MX2017000438A (es) | Solucion cardioplejica de propositos generales (variantes). | |
MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
MX2018007296A (es) | Compuestos de isoindol. | |
MY197171A (en) | Compounds and methods for the treatment of parasitic diseases | |
CL2015002721A1 (es) | Formulaciones oftálmicas | |
RU2019139886A (ru) | Терапевтическое средство против дисфункции мейбомиевых желез | |
BR112017026666A2 (pt) | armazenagem de longo prazo e conservação de plaquetas | |
WO2016048861A3 (en) | Heterocyclic compounds and use thereof | |
CO2021015265A2 (es) | Composiciones y métodos de oximetazolina para el tratamiento de trastornos oculares | |
MX2018008307A (es) | Derivado de ascoclorina y uso del mismo como activador de proteina cinasa activada por adenosin monofosfato (ampk). | |
BR112015022044A2 (pt) | um método de proporcionar neutroproteção ocular | |
MX2019000031A (es) | Procedimientos para la preparación de una solución de levotiroxina. | |
PE20171247A1 (es) | Acidos piridil-cicloalquil-carboxilicos sustituidos, composiciones que los contienen y usos de los mismos | |
JP2016503058A5 (es) | ||
PE20180453A1 (es) | Derivados de acido (s)-2'-vinil-abscisico | |
MX2017000878A (es) | Peptidos marinos y nucleotidos de pescado, composiciones y sus usos para reducir la glucosa en la sangre. |